Corcept Therapeutics Incorporated - CORT
About Gravity Analytica
Recent News
- 09.17.2025 - Mifepristone, a Glucocorticoid Receptor Antagonist, Reduced HbA1c and Body Weight in Difficult-to-control Type 2 Diabetes with Hypercortisolism: The CATALYST Prevalence and Treatment Trial
- 09.17.2025 - Difficult-to-Control Type 2 Diabetes and a Post-Dexamethasone Suppression Test Cortisol of 1.2–1.8 µg/dL: Findings From a Large Prospective Study
- 09.10.2025 - FDA Files Corcept’s New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
- 09.10.2025 - FDA Files Corcept’s New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
Recent Filings
- 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.10.2025 - EX-99.1 EX-99.1
- 09.10.2025 - 8-K Current report
- 09.10.2025 - 144 Report of proposed sale of securities
- 09.08.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities